Table 1.

Baseline demographics of the Trent cohort.

	All patients (n = 104)
Sex (male), n (%)	74 (71)
Age (years)	46.0 (40.0–52.5)
BMI (kg/m2)∗	26.6 (22.8–29.0)
HCV genotype†, n (%)  1  2/3  4/5	38 (39) 57 (58) 3 (3)
Obtained SVR, n (%)	39 (38)
Ishak stage, n (%)  3  4  5  6	42 (41) 21 (20) 20 (19) 21 (20)
Heavy alcohol abuse (>150 U/week), n (%)	5 (5)
Biochemistry
PRO-C3 (ng/ml)	33.2 (17.8–55.0)
ALT	105.0 (72.0–172.0)
ALBI	-2.7 (-2.9 to -2.4)
Liver-related outcomes, n (%)	24 (23)
Follow-up (years), mean (range)	7.9 (0.13, 19.5)

ALBI, albumin–bilirubin; ALT, alanine aminotransferase; SVR, sustained virologic response.

^∗BMI, n = 89.

^†Genotype, n = 98.